Viewing Study NCT02203266


Ignite Creation Date: 2025-12-24 @ 4:42 PM
Ignite Modification Date: 2025-12-30 @ 12:56 AM
Study NCT ID: NCT02203266
Status: COMPLETED
Last Update Posted: 2019-07-18
First Post: 2014-07-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Teaching Inhaler Use With the INCA Device in a Community Pharmacy Setting
Sponsor: Beaumont Hospital
Organization:

Study Overview

Official Title: A Randomised, Parallel-group, Multi-centre Trial Using a Novel INCA Tracker Device to Measure and Monitor Compliance and Technique of Seretide Diskus Inhaler in a Community Pharmacy Setting
Status: COMPLETED
Status Verified Date: 2019-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this trial is to discover whether providing feedback to patients from a device that records when and how well a patient uses a Seretide Diskus inhaler will lead to:

* Improved compliance with prescribed inhaler use
* Improved technique of inhaler use
* A reduction in respiratory health related outcomes caused by poor inhaler compliance and usage.
* An improvement in patient quality of life scores
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: